comparison of glp-1 drugs Mapping the effectiveness and risks receptor agonists Understanding Weight Loss Medications: GLP-1

This paper reviews the physiological, pharmacologic, and clinical foundations linking GLP-1 RA therapy to reproductive outcomes

Learn about their unique characteristics, benefits, side effec...

Curious about microdosing GLP-1s

Learn the most common and serious GLP-1 side effects, including nausea, constipation, pancreatitis risk, and when to seek medical attention.

Approved 20 years ago as a treatment for diabetes, GLP-1 drugs have been found also to help patients significantly reduce weight

95% CI 0.750.98, p=0.03), Dulaglutide (RR 0.82, 95% CI 0.700.96, p=0.02), Albiglutide (RR 0.93,95% CI 0.791.10, p=0.40), Exenatide (RR 0.93, 95% CI 0.741.18, p=0.55), Lixisenatide (RR 0.83, 95% CI 0.621.12, p=0.22), and Efpeglenatide (RR 0.76, 95% CI 0.461.24, p=0.27)